Effect of lntravenous Methylprednisolone (IVMP) on Clinical and Neurophysiological Parameters in Multiple Sclerosis.

Yaşar KÜTÜKÇÜ, Zeki GÖKÇİL, Zeki ODABAŞI, Okay VURAL, Muzaffer YARDIM

Issue: 1996, Volume 2 - Issue 1-2
0 146

THE ROLE OF CYTOKINES IN MULTIPLE SCLEROSIS

Ayşe ALTINTAŞ, Orhun KANTARCI, Aksel SİVA

Issue: 1995, Volume 1 - Issue 4
0 150

Multiple Sclerosis Cases with Atypical Signs

Türe TUNÇBAY, Dilek EVYAPAN, Neşe ÇELEBİSOY

Issue: 1995, Volume 1 - Issue 2
0 143

Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population

Gizem Yağmur Yalçın, Cansu Polat Dunya, Zeliha Tülek, Murat Kürtüncü, Mefkure Eraksoy

DOI: 10.4274/tnd.2021.63444

Issue: 2021, Volume 27 - Supplement 1
0 261

The lmmunopathogenesis of Multiple Sclerosis

Nihal Işık

Issue: 2009, Volume 15 - Supplement 3
0 237

Magnetic Resonance Imaging in the Diagnosis of Multiple Sclerosis

Rana KARABUDAK

Issue: 2009, Volume 15 - Supplement 3
0 265

Multiple Sclerosis Patients with Treatment Failure: Agressive Disease, Switching Treatment, Combination Therapies

Muhteşem GEDİZOĞLU

Issue: 2009, Volume 15 - Supplement 3
0 202

Clinical and Radiological Features of Multiple Sclerosis: Three Case Reports

Murat TERZİ

Issue: 2009, Volume 15 - Supplement 3
0 265

The influence of self-care agency on quality of life in patients with multiple sclerosis

Ahsen Taştan Gürkan, Afitap Özdelikara

DOI: 10.55697/tnd.2024.9

Issue: 2024, Volume 30 - Issue 3
401 204

Determination of important predictors for the fifth-year Expanded Disability Status Scale scores of patients with multiple sclerosis using machine learning

İlknur Buçan Kırkbir, Burçin Kurt, Cavit Boz, Murat Terzi

DOI: 10.55697/tnd.2024.107

Issue: 2024, Volume 30 - Issue 3
335 180